Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels
Testosterone Treatment of Men With Mild Cognitive Impairment and Low Testosterone Levels
复制标题
DOI:
10.1177/1533317514556874
复制
发表时间:
2015-06-01
影响因子:
3.4
通讯作者:
Matsumoto, A. M.
中科院分区:
文献类型:
--
作者:
Cherrier, M. M.;Anderson, K.;Matsumoto, A. M.
Introduction: This study investigated the effects of testosterone (T) treatment on cognition, mood, and quality of life in men with mild cognitive impairment (MCI) and low serum T levels.Methods: A total of 351 community-dwelling men were screened, and 37 men evidenced both MCI and low T of whom 27 agreed for further screening. Twenty-two met all the study inclusion/exclusion criteria and enrolled in a 6-month randomized, double-blind, placebo-controlled study.Results: Total T levels significantly increased in the T treatment group. No significant changes were observed in measures of cognition, mood, or quality of life other than improvement in 1 objective measure of verbal memory (P < .05) and decreased depression symptoms (P < .02) in the treatment group.Conclusions: Testosterone treatment may modestly improve verbal memory and depression symptoms in men with both MCI and low T.